Back to search
Primary Immunodeficiencies
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Immunodeficiencies trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Immunodeficiencies trials you may qualify forChediak-Higashi syndrome (CHS) is a rare autosomal recessive disorder characterized in its classical form by oculocutaneous albinism, a bleeding diathesis, recu…
The Hyper IgE Syndromes (HIES) are primary immunodeficiencies resulting in eczema and recurrent skin and lung infections. Autosomal dominant Hyper IgE syndrome…
This study will examine the role of hereditary factors in different forms of severe combined immunodeficiency (SCID). Patients with immunodeficiencies may be e…
This screening study will examine the causes of immune disorders affecting white blood cells, which defend against infections and will try to develop better mea…
This is a Phase 3, multicenter, 3-part study, with 2 randomized, double-blind, placebo-controlled parts and an open-label extension part, to evaluate the effica…
Background: \- Researchers are interested in studying disorders that make individuals more susceptible to fungal infections, specifically infections with the C…
This study will assess the relative safety, tolerability, and participant satisfaction in participants using the rapid manual push method with Cutaquig®. The hy…
The goal of this clinical trial is to test the drug navenibart in participants with hereditary angioedema (HAE). One group of participants will get 1 dose of na…
The purpose of this study was to evaluate the safety and efficacy of extended dosing of donidalorsen administered subcutaneously (SC), with alternative dosing a…